SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-20-010325
Filing Date
2020-07-14
Accepted
2020-07-14 17:05:57
Documents
14
Period of Report
2020-07-13
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K cort-20200713.htm   iXBRL 8-K 36464
  Complete submission text file 0001628280-20-010325.txt   177698

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cort-20200713.xsd EX-101.SCH 2458
3 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cort-20200713_cal.xml EX-101.CAL 744
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cort-20200713_def.xml EX-101.DEF 1689
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cort-20200713_lab.xml EX-101.LAB 24275
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cort-20200713_pre.xml EX-101.PRE 12680
7 EXTRACTED XBRL INSTANCE DOCUMENT cort-20200713_htm.xml XML 10519
Mailing Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025
Business Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025 650.688.8803
CORCEPT THERAPEUTICS INC (Filer) CIK: 0001088856 (see all company filings)

IRS No.: 770487658 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50679 | Film No.: 201027637
SIC: 2834 Pharmaceutical Preparations